I In addition, CRABP2 promotes lung cancer cell metastasis through HuR and integrin β1/FAK/ERK signaling, and plasma CRABP2 is being used as a novel biomarker in patients with non-small cell lung cancer [20, 21]. This evidence concerns the gene CRABP2 and non-small cell lung carcinoma.